Comparison of primary and key secondary outcomes during the six-month intervention period between study groups adjusted for age, G6PD, haemeoglobin genotype and bednet use in a subset of children^#

#Only five hundred and twenty-nine (529) children who had data on Hb genotype, G6PD status and bednet use were included in this analysis *PE: protective efficacy = (1−relative risk)*100 relative risk was adjusted for Hb genotype, G6PD and net use; since there were zero observations for all cause and malaria admission data are not presented